Retatrutide is a synthetic research peptide currently under investigation as a triple hormone receptor agonist targeting the GIP, GLP-1, and glucagon receptors. This unique receptor profile makes retatrutide a valuable compound for metabolic and energy regulation research, providing insight into the complex pathways involved in glucose balance, lipid metabolism, and energy expenditure.

⸻

Scientific Background

As a next-generation multi-agonist peptide, retatrutide has drawn significant scientific attention for its synergistic effects across multiple metabolic pathways.

By activating GIP, GLP-1, and glucagon receptors simultaneously, researchers have observed strong potential for influencing energy utilization, glycemic control, and fat metabolism in controlled laboratory settings.

This triple-agonist design allows for in-depth exploration of metabolic signaling and receptor interaction dynamics.

⸻

Research Applications

• Studies on multi-agonist peptide mechanisms

• Incretin and glucagon receptor signaling research

• Investigations into glucose and lipid metabolism

• Energy regulation and metabolic modeling studies

⸻

Specifications

• Form: Lyophilized powder

• Purity: ≥98% (HPLC Verified)

°C; protect from light and moisture

• Solubility: Soluble in sterile water or aqueous buffers

• Unit Size: 10 mg vial

⸻

⚠️ Disclaimer

All peptides offered by RH Peptides are intended for laboratory research use only.

Not for human consumption, medical, or veterinary use.

This compound is not approved by the FDA or any other regulatory body for therapeutic application.